|
Title
|
|
|
|
Determining the clinical utility of a breath test for screening an asbestos-exposed population for pleural mesothelioma : baseline results
| |
|
Author
|
|
|
|
| |
|
Abstract
|
|
|
|
| Pleural mesothelioma (PM) is an aggressive cancer of the serosal lining of the thoracic cavity, predominantly caused by asbestos exposure. Due to nonspecific symptoms, PM is characterized by an advanced-stage diagnosis, resulting in a dismal prognosis. However, early diagnosis improves patient outcome. Currently, no diagnostic biomarkers or screening tools are available. Therefore, exhaled breath was explored as this can easily be obtained and contains volatile organic compounds, which are considered biomarkers for multiple (patho)physiological processes. A breath test, which differentiates asbestos-exposed (AEx) individuals from PM patients with 87% accuracy, was developed. However, before being implemented as a screening tool, the clinical utility of the test must be determined. Occupational AEx individuals underwent annual breath tests using multicapillary column/ion mobility spectrometry. A baseline breath test was taken and their individual risk of PM was estimated. PM patients were included as controls. In total, 112 AEx individuals and six PM patients were included in the first of four screening rounds. All six PM patients were correctly classified as having mesothelioma (100% sensitivity) and out of 112 AEx individuals 78 were classified by the breath-based model as PM patients (30% specificity). Given the large false positive outcome, the breath test will be repeated annually for three more consecutive years to adhere to the 'test, re-test' principle and improve the false positivity rate. A low-dose computed tomography scan in those with two consecutive positive tests will correlate test positives with radiological findings and the possible growth of a pleural tumor. Finally, the evaluation of the clinical value of a breath-based prediction model may lead to the initiation of a screening program for early detection of PM in Aex individuals, which is currently lacking. This clinical study received approval from the Antwerp University Hospital Ethics Committee (B300201837007). |
| |
|
Language
|
|
|
|
English
| |
|
Source (journal)
|
|
|
|
Journal of breath research. - Bristol, 2007, currens
| |
|
Publication
|
|
|
|
Bristol
:
IOP
,
2023
| |
|
ISSN
|
|
|
|
1752-7155
[print]
1752-7163
[online]
| |
|
DOI
|
|
|
|
10.1088/1752-7163/ACF7E3
| |
|
Volume/pages
|
|
|
|
17
:4
(2023)
, p. 1-8
| |
|
Article Reference
|
|
|
|
047105
| |
|
ISI
|
|
|
|
001145000600001
| |
|
Pubmed ID
|
|
|
|
37683624
| |
|
Medium
|
|
|
|
E-only publicatie
| |
|
Full text (Publisher's DOI)
|
|
|
|
| |
|
Full text (open access)
|
|
|
|
| |
|
Full text (publisher's version - intranet only)
|
|
|
|
| |
|